Viewing StudyNCT01202591



Ignite Creation Date: 2024-05-05 @ 10:51 PM
Last Modification Date: 2024-10-26 @ 10:25 AM
Study NCT ID: NCT01202591
Status: COMPLETED
Last Update Posted: 2016-02-11
First Post: 2010-09-14

Brief Title: Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs Fulvestrant Alone in ER Breast Cancer Patients
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
FGFR Inhibition Pharmacokinetics Biomarkers
ER Breast Cancer
Keywords:
Name View
Fulvestrant View
Breast Cancer View
ER View
FGFR1 View
Exemestane View
AZD4547 View